|
Volumn 94, Issue 10 Pt 2, 2004, Pages 857-861
|
Appropriate use of the carbapenems.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BETA LACTAM;
CARBAPENEM DERIVATIVE;
CILASTATIN;
ERTAPENEM;
IMIPENEM;
LACTAM;
MEROPENEM;
PROTEINASE INHIBITOR;
THIENAMYCIN DERIVATIVE;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
BACTERIAL PNEUMONIA;
CLASSIFICATION;
CLINICAL PRACTICE;
COMMUNICABLE DISEASE;
CROSS INFECTION;
DRUG UTILIZATION;
HUMAN;
MICROBIOLOGY;
PATIENT SELECTION;
PRACTICE GUIDELINE;
REVIEW;
SOUTH AFRICA;
STANDARD;
SURGICAL INFECTION;
URINARY TRACT INFECTION;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
BETA-LACTAMS;
CARBAPENEMS;
CILASTATIN;
COMMUNITY-ACQUIRED INFECTIONS;
CROSS INFECTION;
DRUG RESISTANCE, BACTERIAL;
DRUG UTILIZATION;
HUMANS;
IMIPENEM;
LACTAMS;
PATIENT SELECTION;
PHYSICIAN'S PRACTICE PATTERNS;
PNEUMONIA, BACTERIAL;
PROTEASE INHIBITORS;
SOUTH AFRICA;
SURGICAL WOUND INFECTION;
THIENAMYCINS;
URINARY TRACT INFECTIONS;
|
EID: 16544387092
PISSN: 02569574
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (35)
|
References (10)
|